Raymond James Downgrades ABIOMED (ABMD) to Market Perform
Raymond James analyst Jayson Bedford downgraded ABIOMED (NASDAQ ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)